# PhiFund Ventures

> PhiFund Ventures is a VC fund backing Health Care, Therapeutics and Medical. See 9 investments, check sizes, portfolio. Updated Aug 2026.

- Type: VC Fund
- Total investments: 9
- Last investment: May 2026
- Lead investor: 11%
- Last updated: Aug 2026
- Website: https://phifundvc.com/

PhiFund Ventures is a VC fund focused on Health Care and Therapeutics. PhiFund focuses on creating and supporting companies that can transform healthcare.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Health Care | 4 | 44% |
| Therapeutics | 4 | 44% |
| Medical | 2 | 22% |
| Biotechnology | 2 | 22% |
| Medical Device | 2 | 22% |

8 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series A | 3 | 33% |
| Venture - Series Unknown | 3 | 33% |
| Seed | 1 | 11% |
| Series B | 1 | 11% |
| Debt Financing | 1 | 11% |

### Country

| Country | Investments | Share |
| --- | --- | --- |
| United States | 4 | 44% |
| Israel | 1 | 11% |
| Germany | 1 | 11% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Vortex Imaging | Vortex Imaging develops medical imaging devices. | $12M | Venture - Series Unknown | May 18, 2026 |  |
| Leal Therapeutics | Leal Therapeutics develops novel therapeutics for patients. | $30M | Series A | Aug 27, 2025 |  |
| VeraDermics | Veradermics is a dermatology-focused biopharmaceutical company that develops treatments for common skin and hair conditions. Its lead drug candidate, VDPHL01, is an extended-release oral minoxidil being tested in Phase 3 clinical trials for pattern hair loss in both women and men. The company also has pipeline programs targeting conditions such ascommon warts, molluscum contagiosum, and atopic dermatitis. | $75M | Series B | Dec 11, 2024 |  |
| Leal Therapeutics | Leal Therapeutics develops novel therapeutics for patients. |  | Debt Financing | Oct 30, 2024 |  |
| Leal Therapeutics | Leal Therapeutics develops novel therapeutics for patients. | $6M | Venture - Series Unknown | Oct 30, 2024 |  |
| Cirsium Biosciences | Cirsium Biosciences is a cutting-edge production technology, harness transient gene delivery in plants and high-density Controlled Environment Agriculture (CEA) to produce high-quality AAV vectors for genetic medicine. |  | Venture - Series Unknown | Jul 10, 2024 |  |
| SciRhom | SciRhom GmbH is a biotech company that translates science into the preclinical and early clinical development of novel biopharmaceuticals for the treatment of life-threatening autoimmune diseases. Based on longstanding academic research and a well-established network of experts, SciRhom was founded in 2016 through a collaboration between academicand industry scientists with profound experience in antibody development. | $68.1M | Series A | Jul 09, 2024 |  |
| Switch Therapeutics | Switch Therapeutics is a biotech company that develops RNAi therapies based on technology. The company was founded in 2020 and is based in San Francisco, California, United States. | $52M | Series A | Mar 14, 2023 |  |
| Leal Therapeutics | Leal Therapeutics develops novel therapeutics for patients. | $39M | Seed | Jan 01, 2022 |  |

9 of 9 investments shown.

## Co-investors
- [OrbiMed](https://shizune.co/investors/profile/orbimed-advisors) — VC Fund, 4 deals together
- [Alexandria Venture Investments](https://shizune.co/investors/profile/alexandria-venture-investments) — VC Fund, 3 deals together
- [Chugai Venture Fund](https://shizune.co/investors/profile/chugai-venture-fund) — VC Fund, 3 deals together
- [Euclidean Capital](https://shizune.co/investors/profile/euclidean-capital) — VC Fund, 3 deals together
- [Newpath Management](https://shizune.co/investors/profile/newpath-management-l-p) — VC Fund, 3 deals together
- [Connecticut Innovations](https://shizune.co/investors/profile/connecticut-innovations) — VC Fund, 2 deals together

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

## FAQ

### What does PhiFund Ventures invest in?

PhiFund Ventures invests primarily in Health Care, Therapeutics and Medical startups, most often at Series A and Venture - Series Unknown stage. Most of the 9 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did PhiFund Ventures last invest?

The most recent investment recorded for PhiFund Ventures closed in May 2026. Shizune tracks 9 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co